Literature DB >> 34999896

Does Pain Medication Use Influence the Outcome of 8 Weeks of Education and Exercise Therapy in Patients with Knee or Hip Osteoarthritis? An Observational Study.

Bart W Koes1,2, Alessandro Chiarotto1, Jonas Bloch Thorlund2,3, Dorte Thalund Grønne2, Ewa M Roos2, Søren T Skou2,4.   

Abstract

OBJECTIVE: Patients with osteoarthritis are mainly managed in primary care settings and many patients use pain medication as symptomatic treatment. We investigated in OA-patients receiving an education and exercise program, the use and type of pain medication and its impact on outcomes at 3 months follow-up. DESIGN, SETTING AND
SUBJECTS: The design was a retrospective cohort study using prospectively collected data from the GLA: D® registry. The study included 15,918 primary care patients.
RESULTS: Among the included patients, 62% were pain medication users and 38% were non-users. Among the pain medications users, 35% were classified as paracetamol users, 54% as NSAID users, and 11% as opioid users. Medication users and non-users differed regarding a higher pain intensity, poorer physical and mental health. Pain medication use before and during the education and exercise program was associated with the pain intensity at 3 months follow-up. However, patients either using or not using pain medications improved over time, and the magnitude of the difference between patient groups was small (less than 10 mm on a 0-100 scale).
CONCLUSIONS: Pain medication use is weakly associated with outcome at 3 months follow up in OA-patients receiving an education and exercise program. Between-group differences, however, are small and probably not clinically important.
© The Author(s) 2022. Published by Oxford University Press on behalf of the American Academy of Pain Medicine.

Entities:  

Keywords:  Cohort Study; Hip Osteoarthritis; Knee Osteoarthritis; Outcome; Pain Medication

Mesh:

Year:  2022        PMID: 34999896      PMCID: PMC9340625          DOI: 10.1093/pm/pnab352

Source DB:  PubMed          Journal:  Pain Med        ISSN: 1526-2375            Impact factor:   3.637


  19 in total

1.  Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): explanation and elaboration.

Authors:  Jan P Vandenbroucke; Erik von Elm; Douglas G Altman; Peter C Gøtzsche; Cynthia D Mulrow; Stuart J Pocock; Charles Poole; James J Schlesselman; Matthias Egger
Journal:  Epidemiology       Date:  2007-11       Impact factor: 4.822

Review 2.  Knee pain and osteoarthritis in older adults: a review of community burden and current use of primary health care.

Authors:  G Peat; R McCarney; P Croft
Journal:  Ann Rheum Dis       Date:  2001-02       Impact factor: 19.103

3.  Recommendation Rates for Physical Therapy, Lifestyle Counseling, and Pain Medications for Managing Knee Osteoarthritis in Ambulatory Care Settings: A Cross-Sectional Analysis of the National Ambulatory Care Survey (2007-2015).

Authors:  Samannaaz S Khoja; Gustavo J Almeida; Janet K Freburger
Journal:  Arthritis Care Res (Hoboken)       Date:  2020-02       Impact factor: 4.794

4.  Patients use fewer analgesics following supervised exercise therapy and patient education: an observational study of 16 499 patients with knee or hip osteoarthritis.

Authors:  Jonas Bloch Thorlund; Ewa M Roos; Patricia Goro; Emily Gromelsky Ljungcrantz; Dorte Thalund Grønne; Søren T Skou
Journal:  Br J Sports Med       Date:  2020-09-21       Impact factor: 13.800

Review 5.  Measures of adult pain: Visual Analog Scale for Pain (VAS Pain), Numeric Rating Scale for Pain (NRS Pain), McGill Pain Questionnaire (MPQ), Short-Form McGill Pain Questionnaire (SF-MPQ), Chronic Pain Grade Scale (CPGS), Short Form-36 Bodily Pain Scale (SF-36 BPS), and Measure of Intermittent and Constant Osteoarthritis Pain (ICOAP).

Authors:  Gillian A Hawker; Samra Mian; Tetyana Kendzerska; Melissa French
Journal:  Arthritis Care Res (Hoboken)       Date:  2011-11       Impact factor: 4.794

6.  Opioids for chronic osteoarthritis pain: An updated systematic review and meta-analysis of efficacy, tolerability and safety in randomized placebo-controlled studies of at least 4 weeks double-blind duration.

Authors:  Patrick Welsch; Frank Petzke; Petra Klose; Winfried Häuser
Journal:  Eur J Pain       Date:  2020-01-17       Impact factor: 3.931

Review 7.  Celecoxib for osteoarthritis.

Authors:  Livia Puljak; Ana Marin; Davorka Vrdoljak; Filipa Markotic; Ana Utrobicic; Peter Tugwell
Journal:  Cochrane Database Syst Rev       Date:  2017-05-22

8.  Good Life with osteoArthritis in Denmark (GLA:D™): evidence-based education and supervised neuromuscular exercise delivered by certified physiotherapists nationwide.

Authors:  Søren T Skou; Ewa M Roos
Journal:  BMC Musculoskelet Disord       Date:  2017-02-07       Impact factor: 2.362

9.  Population trends in the incidence and initial management of osteoarthritis: age-period-cohort analysis of the Clinical Practice Research Datalink, 1992-2013.

Authors:  Dahai Yu; Kelvin P Jordan; John Bedson; Martin Englund; Fiona Blyth; Aleksandra Turkiewicz; Daniel Prieto-Alhambra; George Peat
Journal:  Rheumatology (Oxford)       Date:  2017-11-01       Impact factor: 7.580

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.